Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
SCAL
vs
S&P 500
SCAL
S&P 500
Over the past 12 months, SCAL has underperformed S&P 500, delivering a return of 0% compared to S&P 500's +15% growth.
Stocks Performance
SCAL vs S&P 500
Performance Gap
SCAL vs S&P 500
Performance By Year
SCAL vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Stem Cell Authority Ltd
Glance View
Stem Cell Authority, Ltd. is a clinical-stage biopharmaceutical company committed to the research and development of immune system disease treatments using small molecules and stem cell technology. The company is headquartered in Fairlawn, Ohio. The company went IPO on 2005-01-11. The firm is focused on the collection and cryogenic preservation of the Hematopoietic stem cells from the umbilical cord blood, and the MirachymalSM stem cells from the Wharton’s jelly inside the umbilical cord of a newborn child. The firm is engaged in offering preservation of two types of stem cells to parents in the United States. Miracle Mesenchymal (MirachymalSM) stem cells are extracted from the Wharton’s Jelly inside the umbilical cord after the birth of a baby. These stem cells create specialized cells in the body that make up the musculo-skeletal system (bone, cartilage, fibrous tissue and muscle). Mesenchymal stem cells have special immune-regulatory functions and are used to treat immune and inflammatory diseases.
